Ipsen (XPAR:IPN) Inventories, Finished Goods : €93 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Ipsen Inventories, Finished Goods?

Ipsen's quarterly finished goods increased from Dec. 2022 (€100 Mil) to Jun. 2023 (€124 Mil) but then declined from Jun. 2023 (€124 Mil) to Dec. 2023 (€93 Mil).

Ipsen's annual finished goods declined from Dec. 2021 (€109 Mil) to Dec. 2022 (€100 Mil) and declined from Dec. 2022 (€100 Mil) to Dec. 2023 (€93 Mil).

Ipsen Inventories, Finished Goods Historical Data

The historical data trend for Ipsen's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Inventories, Finished Goods Chart

Ipsen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

118.10

112.10

108.90

100.40

92.50

Ipsen Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Inventories, Finished Goods	Get a 7-Day Free Trial															108.30	100.40	123.50	92.50	-

Ipsen Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Ipsen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (XPAR:IPN) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

IPSEY:USA IPSEF:USA IPNp:UK 0MH6:UK I7G:Germany

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.